1. Home
  2. OLMA vs SISI Comparison

OLMA vs SISI Comparison

Compare OLMA & SISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • SISI
  • Stock Information
  • Founded
  • OLMA 2006
  • SISI 1997
  • Country
  • OLMA United States
  • SISI China
  • Employees
  • OLMA N/A
  • SISI N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • SISI Medicinal Chemicals and Botanical Products
  • Sector
  • OLMA Health Care
  • SISI Health Care
  • Exchange
  • OLMA Nasdaq
  • SISI Nasdaq
  • Market Cap
  • OLMA 299.7M
  • SISI 305.3M
  • IPO Year
  • OLMA 2020
  • SISI 2016
  • Fundamental
  • Price
  • OLMA $5.76
  • SISI $5.77
  • Analyst Decision
  • OLMA Strong Buy
  • SISI
  • Analyst Count
  • OLMA 5
  • SISI 0
  • Target Price
  • OLMA $24.00
  • SISI N/A
  • AVG Volume (30 Days)
  • OLMA 532.6K
  • SISI 1.8M
  • Earning Date
  • OLMA 08-11-2025
  • SISI 09-29-2025
  • Dividend Yield
  • OLMA N/A
  • SISI N/A
  • EPS Growth
  • OLMA N/A
  • SISI N/A
  • EPS
  • OLMA N/A
  • SISI N/A
  • Revenue
  • OLMA N/A
  • SISI $9,601,324.00
  • Revenue This Year
  • OLMA N/A
  • SISI N/A
  • Revenue Next Year
  • OLMA N/A
  • SISI N/A
  • P/E Ratio
  • OLMA N/A
  • SISI N/A
  • Revenue Growth
  • OLMA N/A
  • SISI 1133.26
  • 52 Week Low
  • OLMA $2.86
  • SISI $4.71
  • 52 Week High
  • OLMA $13.93
  • SISI $768.00
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 63.92
  • SISI 40.53
  • Support Level
  • OLMA $5.34
  • SISI $5.43
  • Resistance Level
  • OLMA $5.78
  • SISI $7.82
  • Average True Range (ATR)
  • OLMA 0.34
  • SISI 1.00
  • MACD
  • OLMA 0.05
  • SISI 0.24
  • Stochastic Oscillator
  • OLMA 85.90
  • SISI 32.22

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About SISI Shineco Inc.

Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed various vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.

Share on Social Networks: